Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FDI - WINDOW OF OPPORTUNITY<br />
Aarti Industries Ltd.<br />
CMP: Rs 520<br />
Rating: BUY Target: Rs 620<br />
Company Information<br />
BSE Code 524208<br />
NSE Code<br />
AARTIIND<br />
Bloomberg Code<br />
ARTO<br />
ISIN<br />
INE769A01020<br />
Market Cap (Rs. Cr) 4329<br />
Outstanding shares(Cr) 8.3<br />
52-wk Hi/Lo (Rs.) 587 / 315.2<br />
Avg. daily volume (1yr. on NSE) 60,625<br />
Face Value(Rs.) 5<br />
Book Value 121.6<br />
190<br />
170<br />
150<br />
130<br />
110<br />
90<br />
70<br />
50<br />
Jun-15<br />
Jul-15<br />
Aug-15<br />
Sep-15<br />
AARTIIND vs. Nifty<br />
Oct-15<br />
Nov-15<br />
Dec-15<br />
Share holding pattern as on Mar <strong>2016</strong> (%)<br />
Particulars (in Rs. Cr.) FY15 FY16 FY17E FY18E<br />
Net Sales 2908.0 2779.6 3305.0 3817.2<br />
Growth (%) 10.5 (4.4) 18.9 15.5<br />
EBITDA 465.7 572.3 687.4 790.2<br />
EBITDA Margin (%) 16.0 20.6 20.8 20.7<br />
Net profit 203.2 256.9 317.3 374.1<br />
Net Profit Margin (%) 7.0 9.2 9.6 9.8<br />
EPS (Rs) 23.2 30.8 38.1 44.9<br />
Jan-16<br />
Feb-16<br />
Mar-16<br />
Consensus Estimate: Bloomberg, <strong>Ashika</strong> Research<br />
Apr-16<br />
May-16<br />
Volume('000)RHS AARTIIND Nifty<br />
Others<br />
29.5<br />
DII<br />
12.4<br />
FII<br />
3.3<br />
Promoters<br />
54.8<br />
900<br />
800<br />
700<br />
600<br />
500<br />
400<br />
300<br />
200<br />
100<br />
0<br />
Company Overview<br />
Aarti Industries Ltd (AIL) is one of the largest producers of<br />
Benzene-based basic and intermediate chemicals in India<br />
and manufactures 125 products with chemistry of<br />
benzene, aniline, sulphuric acid, toluene and methanol. AIL<br />
is one of the leading global suppliers of dyes, pigments,<br />
agrochemicals, pharmaceuticals and rubber chemicals. The<br />
company has three reportable segments - Speciality<br />
Chemicals, Pharmaceuticals and Home & Personal Care<br />
Chemicals. Aarti has 16 manufacturing units spread across<br />
Gujarat & Maharashtra and a strong Research &<br />
Development with sophisticated instruments & pool of<br />
scientists. Aarti has customers spread across the globe in<br />
60 countries with major presence in USA, Europe, Japan &<br />
India.<br />
Investment Rationale<br />
Capacity Expansion to boost growth<br />
Over the next three years Aarti is undertaking a capex of<br />
~Rs 500 crore to expand capacities across benzene,<br />
toluene and ethylene, and nitro toluene based value<br />
chains. Ongoing expansion projects of the company that<br />
are likely to be commenced in FY17 are Calcium Chloride<br />
Unit at Jhagadia, Ethylation Facility at Dahej, Nitration Unit<br />
at Jhagadia (NitroToulene & Downstreams) and NCB<br />
Expansion at Vapi. These capacities are planned to<br />
capitalize on opportunities emerging from growing enduser<br />
markets, capacity shut downs in developed markets<br />
and reduced global supplies from China and firm off-take<br />
commitments from global agrochemical majors for<br />
exclusive supply. With the help of these enhanced<br />
capacities and adding several value added products in its<br />
portfolio, it is expected that in the coming years both<br />
topline and bottomline of the company will improve. Apart<br />
from this, Aarti is also in the process of setting up a multi<br />
purpose specialty chemicals complex at Jhagadia to<br />
manufacture a range of high end polymers and<br />
engineering plastics that are used in the automobile<br />
industry. This project will add value growth from FY18.<br />
Demerger plan<br />
Pharma and personal care ingredient manufacturing are<br />
non core to Aarti’s specialty chemicals operation and are<br />
relatively low efficient/profitable operations. Hence, in<br />
order to focus more on value added specialty chemicals,<br />
Aarti is likely to demerge these businesses which will<br />
unlock value. Previously it was expected that the demerger<br />
13